Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

Dec 14, 2020

Axonics® Announces Appointment of David M. Demski to Board of Directors

Nov 19, 2020

Axonics® to Participate in Piper Sandler Virtual Healthcare Conference

Nov 10, 2020

Axonics® Announces Publication of Fecal Incontinence Study Results for Patients Treated with r-SNM® System

Nov 04, 2020

Axonics® Reports Third Quarter 2020 Results

Oct 29, 2020

Axonics® Submits PMA Supplement to FDA to Further Expand MRI Labeling

Oct 20, 2020

Axonics® Launches ARTISTRY Study to Collect and Analyze Real-World Data of Patients Implanted with the Axonics r-SNM System

Oct 14, 2020

Axonics® to Report Third Quarter 2020 Results on November 4

Oct 07, 2020

Axonics® CEO Raymond W. Cohen Named Ernst & Young Entrepreneur of the Year® 2020 Award Winner for Orange County

Oct 05, 2020

Axonics® Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim II

Sep 24, 2020

Axonics® Provides Update on Inter Partes Review Proceedings

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Next page
Last page

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

©2021 Axonics Modulation Technologies, Inc. Axonics^® and Axonics Modulation Technologies^® are trademarks of Axonics Modulation Technologies, Inc., registered or pending registration in the U.S. and other countries.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap